Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06417502
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-05-07
Brief Title:
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China The CAPRID Registry
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Study Overview
Official Title:
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China The CAPRID Registry
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An observational multi-center longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases
Detailed Description:
Pediatric rheumatic and immunologic diseases severely impact the health of children and adolescents Chinese Alliance of Pediatric Rheumatic Immunologic Diseases CAPRID was founded in 2022 to form a national collaboration for high-quality data-driven multi-center pediatric rheumatology and immunology research in China The CAPRID Registry is an observational multi-center longitudinal registry for Chinese pediatric patients with rheumatic and immunologic diseases to explore the clinical phenotypes diagnoses complications real-world drug safety therapeutic efficacy adverse events critical illness and outcomes of Chinese pediatric patients with rheumatic and immunologic diseases
Hospital-based databases are established and standardized with Observational Medical Outcomes Partnership OMOP Common Data Model CDM for routine data collection A web-based registry website is established with standardized electronic case report forms to register patients from CAPRID centers A mobile application is created to allow long-term follow up and patient-reported outcome collection The data captured in this registry reflects a real world situation with no intervention done outside the routine clinical practice Treatment plans are determined by the investigator
Hospital-based databases are established and standardized with Observational Medical Outcomes Partnership OMOP Common Data Model CDM for routine data collection A web-based registry website is established with standardized electronic case report forms to register patients from CAPRID centers A mobile application is created to allow long-term follow up and patient-reported outcome collection The data captured in this registry reflects a real world situation with no intervention done outside the routine clinical practice Treatment plans are determined by the investigator
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2021YFC2702000 | OTHER_GRANT | National Key RD Program of China | None |